This grant is for the purpose of funding research to deeply comprehend Immune-CNS interactions in people living with HIV who are on Anti-Retroviral Therapy (ART). Despite ART’s success, many individuals still experience neurological and cognitive challenges. This initiative aims to support studies that decipher the precise mechanisms of how the immune system affects the central nervous system in this population. This understanding will foster novel therapeutic targets and improved interventions. Ultimately, this effort seeks to enhance the neurological health and quality of life for people living with HIV.
Opportunity ID: 335373
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-MH-21-250 |
| Funding Opportunity Title: | Deciphering Immune-CNS interactions in people living with HIV on Anti-Retroviral therapy (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.242 — Mental Health Research Grants |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 19, 2021 |
| Last Updated Date: | Aug 19, 2021 |
| Original Closing Date for Applications: | Dec 07, 2021 |
| Current Closing Date for Applications: | Dec 07, 2021 |
| Archive Date: | Jan 12, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Special district governments Private institutions of higher education City or township governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities For profit organizations other than small businesses State governments Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts County governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This initiative is to support studies to better comprehend Immune-CNS interactions in people living with HIV on Anti-Retroviral therapy. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-250.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269884 | Nov 07, 2021 | Dec 07, 2021 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00268649 | Nov 07, 2021 | Jan 24, 2022 | View |
Package 1
Mandatory forms
335373 RR_SF424_5_0-5.0.pdf
335373 PHS398_CoverPageSupplement_5_0-5.0.pdf
335373 RR_OtherProjectInfo_1_4-1.4.pdf
335373 PerformanceSite_4_0-4.0.pdf
335373 RR_KeyPersonExpanded_4_0-4.0.pdf
335373 PHS398_ResearchPlan_4_0-4.0.pdf
335373 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
335373 RR_Budget_3_0-3.0.pdf
335373 RR_SubawardBudget30_3_0-3.0.pdf
335373 PHS398_ModularBudget_1_2-1.2.pdf
335373 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
335373 RR_SF424_2_0-2.0.pdf
335373 PHS398_CoverPageSupplement_5_0-5.0.pdf
335373 RR_OtherProjectInfo_1_4-1.4.pdf
335373 PerformanceSite_2_0-2.0.pdf
335373 RR_KeyPersonExpanded_2_0-2.0.pdf
335373 PHS398_ResearchPlan_4_0-4.0.pdf
335373 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
335373 RR_Budget_1_4-1.4.pdf
335373 RR_SubawardBudget30_1_4-1.4.pdf
335373 PHS398_ModularBudget_1_2-1.2.pdf
335373 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
